Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women

Annals of Internal Medicine

Volumn 131, Issue 8, 1999, Pages 573-577

  Ridker, Paul M ^a   Hennekens, Charles H ^a   Buring, Julie E ^a   Kundsin, Ruth ^a   Shih, Jessie ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY TITER; ARTICLE; CARDIOVASCULAR DISEASE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORONARY RISK; CYTOMEGALOVIRUS; HELICOBACTER PYLORI; HERPES SIMPLEX VIRUS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0032747961     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-131-8-199910190-00004     Document Type: Article

References (20)

1. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997;350:430-6.
2. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation. 1997;96:4095-103.
3. Ridker PM. Inflammation, infection, and cardiovascular risk: how good is the clinical evidence? [Editorial] Circulation. 1998;97:1671-4.
4. Saikku P, Leinonen M, Tenkanen L, Linnanmäki E, Ekman MR, Manninen V, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med. 1992; 116:273-8.
5. Miettinen H, Lehto S, Saikku P, Haffner SM, Ronnemaa T, Pyorala K, et al. Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. Eur Heart J. 1996;17:682-8.
6. Ridker PM, Kundsin RB, Stampfer MJ, Poulin S, Hennekens CH. A prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation. 1999;99:1161-4.
7. Strachan DP, Carrington D, Mendall MA, Ballam L, Morris J, Butland BK, et al. Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the Caerphilly prospective heart disease study. BMJ. 1999;318:1035-9.
8. Strachan DP, Mendall MA, Carrington D, Butland BK, Yarnell JW, Sweetnam PM, et al. Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the Caerphilly prospective heart disease study. Circulation. 1998;98:1286-90.
9. Wald NJ, Law MR, Morris JK, Bagnall AM. Helicobacter pylori infection and mortality from ischaemic heart disease: negative results from a large, prospective study. BMJ. 1997;315:1199-201.
10. Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle-aged men. Heart. 1996;75:568-72.
11. Strandberg TE, Tilvis RS, Vuoristo M, Lindroos M, Kosunen TU. Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population. BMJ. 1997;314:1317-8.
12. Folsom AR, Nieto FJ, Sorlie P, Chambless LE, Graham DY. Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study Investigators. Circulation. 1998;98:845-50.
13. Ridker PM, Hennekens CH, Stampfer MJ, Wang F. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation. 1998;98:2796-9.
14. Zhu J, Quyyumi AA, Norman JE, Csako GA, Shearer GM, Grayston JT, et al. Total pathogen burden contributes incrementally to coronary artery disease risk and to C-reactive protein levels [Abstract]. Circulation. 1998;98: 1-42.
15. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1993;98:731-3.
16. Buring JE, Hennekens CH. The Women's Health Study: summary of the study design. Journal of Myocardial Ischemia. 1992;4:27-9.
17. Wang SP, Grayston JT. Microimmunofluorescence serology in Chlamydia trachomatis. In: de la Maza LM, ed. 1983 International Symposium on Medical Virology. New York: Elsevier Biomedical; 1984:87-118.
18. Rothman KJ. Modern Epidemiology. Boston: Little, Brown; 1986:346-9.
19. Ridker PM, Manson JE, Buring JE, Shih J, Matias M, Hennekens CH. Homocysteine and risk of cardiovascular disease among postmenopausal women. JAMA. 1999;281:1817-21.
20. Davidson M, Kuo CC, Middaugh JP, Campbell LA, Wang SP, Newman WP 3d, et al. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation. 1998; 98:628-33.